StockNews.com initiated coverage on shares of Jaguar Health (NASDAQ:JAGX – Get Free Report) in a research report issued on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock.
Jaguar Health Stock Performance
NASDAQ JAGX opened at $0.31 on Wednesday. The company has a 50-day moving average price of $0.13 and a two-hundred day moving average price of $0.18. The company has a debt-to-equity ratio of 6.33, a quick ratio of 1.34 and a current ratio of 2.00. Jaguar Health has a 52 week low of $0.05 and a 52 week high of $1.22.
Jaguar Health Company Profile
Featured Articles
- Five stocks we like better than Jaguar Health
- P/E Ratio Calculation: How to Assess Stocks
- Roblox: The Bottom Just Fell Out of the Metaverse
- Options Trading – Understanding Strike Price
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Why Invest in Biotech Stocks
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.